For research use only. Not for therapeutic Use.
CDD3505 is used for elevating high density lipoprotein cholesterol (HDL) by inducing hepatic cytochrome P450IIIA (CYP3A) activity.
CDD3505 specifically induces hepatic cytochrome P450IIIA produces significant increases in HDL cholesterol[1].
| Catalog Number | I002264 |
| CAS Number | 173865-33-3 |
| Synonyms | 4-nitro-1-tritylimidazole |
| Molecular Formula | C22H17N3O2 |
| Purity | ≥95% |
| InChI | InChI=1S/C22H17N3O2/c26-25(27)21-16-24(17-23-21)22(18-10-4-1-5-11-18,19-12-6-2-7-13-19)20-14-8-3-9-15-20/h1-17H |
| InChIKey | MUQGVERJAKANJN-UHFFFAOYSA-N |
| SMILES | C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3)N4C=C(N=C4)[N+](=O)[O-] |
| Reference | [1]. Method for increasing HDL cholesterol levels?using?heteroaromatic phenylmethanes. United States Patent 6103733 |
